(Q51512007)

6 April 2018

title

Osteoprotegerin (OPG) and receptor activator of NF-kB ligand (RANK-L) serum levels in patients on chronic hemodialysis. (English)

1 reference

6 April 2018

author name string

S Gonnelli

1

1 reference

6 April 2018

A Montagnani

2

1 reference

6 April 2018

C Caffarelli

3

1 reference

6 April 2018

A Cadirni

4

1 reference

6 April 2018

M S Campagna

5

1 reference

6 April 2018

M B Franci

6

1 reference

6 April 2018

B Lucani

7

1 reference

6 April 2018

E Gaggiotti

8

1 reference

6 April 2018

R Nuti

9

1 reference

6 April 2018

publication date

1 June 2005

1 reference

6 April 2018

Journal of Endocrinological Investigation

published in

1 reference

6 April 2018

volume

28

1 reference

6 April 2018

issue

6

1 reference

6 April 2018

page(s)

534-539

1 reference

6 April 2018

https://scigraph.springernature.com/pub.10.1007/bf03347242

exact match

0 references

cites work

Update on renal osteodystrophy: pathogenesis and clinical management

1 reference

https://api.crossref.org/works/10.1007%2FBF03347242

Review on uremic toxins: classification, concentration, and interindividual variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347242

The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347242

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347242

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347242

Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347242

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347242

PTH differentially regulates expression of RANKL and OPG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347242

Osteoprotegerin and bone mineral metabolism in renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347242

Serum osteoprotegerin and renal osteodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347242

Osteoprotegerin and parathyroid hormone as markers of high-turnover osteodystrophy and decreased bone mineralization in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347242

The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347242

Osteoprotegerin: a physiological and pharmacological inhibitor of bone resorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347242

The role of cytokines in skeletal remodelling: possible consequences for renal osteodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347242

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347242

PTH 1-84 and PTH "7-84" in the noninvasive diagnosis of renal bone disease

21 January 2018

1 reference

12 December 2020

Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation

1 reference

12 December 2020

Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women

1 reference

12 December 2020

The spectrum of bone disease in end-stage renal failure--an evolving disorder

1 reference

12 December 2020

Increased levels of osteoprotegerin in hemodialysis patients

1 reference

12 December 2020

Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients

1 reference

12 December 2020

Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro

1 reference

12 December 2020

A novel mechanism for skeletal resistance in uremia

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03347242

1 reference

6 April 2018

PubMed ID

16117195

1 reference

6 April 2018